Becton, Dickinson and Company (BDX) Stock Forecast & Price Target

$243.75

+3.42 (+1.42%)

(As of 10/18/2024 ET)

Becton, Dickinson and Company - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 8 Analyst Ratings

Sell
0

Hold
0

Buy
8

Based on 8 Wall Street analysts who have issued ratings for Becton, Dickinson and Company in the last 12 months, the stock has a consensus rating of "Buy." Out of the 8 analysts, 8 have given a buy rating for BDX.

Consensus Price Target

$282.63
15.95% Upside

According to the 8 analysts' twelve-month price targets for Becton, Dickinson and Company, the average price target is $282.63. The highest price target for BDX is $312.00, while the lowest price target for BDX is $270.00. The average price target represents a forecasted upside of 15.95% from the current price of $243.75.

BDX Analyst Ratings Over Time

Type	Current Forecast 10/21/23 to 10/20/24	1 Month Ago 9/21/23 to 9/20/24	3 Months Ago 7/23/23 to 7/22/24	1 Year Ago 10/21/22 to 10/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	8 Buy rating(s)
Hold	0 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$282.63	$279.50	$280.14	$286.00
Forecasted Upside	15.95% Upside	19.70% Upside	21.23% Upside	10.58% Upside
Consensus Rating	Buy	Moderate Buy	Moderate Buy	Moderate Buy

Have you heard of Donald Trump’s Project Crypto? (Ad)

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Learn More Here

BDX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Becton, Dickinson and Company Stock vs. The Competition

Type	Becton, Dickinson and Company	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.79	2.50
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	15.95% Upside	13,587.63% Upside	6.20% Upside
News Sentiment Rating	Positive News See Recent BDX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/1/2024	Evercore ISI 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$286.00 ➝ $290.00	+20.29%
10/1/2024	Citigroup 3 of 5 stars	J. Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$255.00 ➝ $275.00	+14.08%
8/2/2024	Raymond James 4 of 5 stars		Lower Target	Outperform ➝ Outperform	$275.00 ➝ $270.00	+12.55%
7/26/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$270.00 ➝ $280.00	+17.80%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$274.00	+21.82%
5/6/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$305.00 ➝ $312.00	+31.85%
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately.
12/4/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$310.00 ➝ $280.00	+17.52%
11/10/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$305.00 ➝ $280.00	+19.33%
1/3/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$250.00 ➝ $290.00	+14.04%
11/16/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$255.00	+14.89%
11/11/2022	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Brackmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:38 AM ET.

Should I Buy Becton, Dickinson and Company Stock? BDX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 11, 2024. Please send any questions or comments about these Becton, Dickinson and Company pros and cons to contact@marketbeat.com.

Becton, Dickinson and Company
Bull Case

Here are some ways that investors could benefit from investing in Becton, Dickinson and Company:

Becton, Dickinson and Company has consistently shown strong financial performance, with a return on equity of 14.49% and a net margin of 7.13%, indicating efficient use of shareholder equity and profitability.
The company has a stable dividend payout ratio of 83.70%, providing investors with a reliable income stream. The current dividend yield of 1.57% is attractive for income-oriented investors.
Analysts have given Becton, Dickinson and Company a "Moderate Buy" rating with an average target price of $279.50, suggesting potential for stock price appreciation.
Recent analyst reports have upgraded the company's rating to "buy" and increased price targets, indicating positive sentiment and growth potential in the stock.
Despite market fluctuations, Becton, Dickinson and Company has maintained a strong market position with a market capitalization of $69.80 billion, reflecting investor confidence in the company's long-term prospects.

Becton, Dickinson and Company
Bear Case

Investors should be bearish about investing in Becton, Dickinson and Company for these reasons:

While the company has shown solid financial performance, the stock's current PE ratio of 53.20 and P/E/G ratio of 1.92 may indicate that the stock is currently overvalued, potentially limiting short-term upside for investors.
The recent reduction in price targets by some analysts, such as Citigroup cutting the target from $260.00 to $255.00, may suggest concerns about future growth prospects or market conditions affecting the company.
Market volatility and economic uncertainties could impact Becton, Dickinson and Company's revenue growth, as seen in the slight revenue decline compared to analyst estimates in the latest earnings report.
The company's stock price has fluctuated between a one-year low of $218.75 and a high of $269.52, indicating potential volatility that may not align with all investors' risk tolerance levels.
With a debt-to-equity ratio of 0.70, Becton, Dickinson and Company carries a moderate level of debt, which could pose risks in case of economic downturns or interest rate changes affecting borrowing costs.

BDX Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Becton, Dickinson and Company is $282.63, with a high forecast of $312.00 and a low forecast of $270.00.
: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and Company in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BDX shares.
: According to analysts, Becton, Dickinson and Company's stock has a predicted upside of 15.95% based on their 12-month stock forecasts.
: Over the previous 90 days, Becton, Dickinson and Company's stock had 1 upgrade by analysts.
: Becton, Dickinson and Company has been rated by research analysts at Citigroup, Evercore ISI, Raymond James, and Stifel Nicolaus in the past 90 days.
: Analysts like Becton, Dickinson and Company more than other "medical" companies. The consensus rating for Becton, Dickinson and Company is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BDX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

This page (NYSE:BDX) was last updated on 10/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Becton, Dickinson and Company (BDX) Stock Forecast & Price Target